Pfizer
PFE
2,676 hedge funds and large institutions have $133B invested in Pfizer in 2021 Q1 according to their latest regulatory filings, with 167 funds opening new positions, 1,222 increasing their positions, 1,083 reducing their positions, and 133 closing their positions.
26% more first-time investments, than exits
New positions opened: 167 | Existing positions closed: 133
13% more repeat investments, than reductions
Existing positions increased: 1,222 | Existing positions reduced: 1,083
0% more funds holding
Funds holding: 2,676 → 2,676 (0)
0.88% less ownership
Funds ownership: 66.77% → 65.89% (-0.88%)
14% less call options, than puts
Call options by funds: $1.88B | Put options by funds: $2.18B
16% less funds holding in top 10
Funds holding in top 10: 64 → 54 (-10)
18% less capital inflows, than outflows
Capital inflows: $5.03B | Capital outflows: $6.14B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$336M |
| 2 |
BlackRock
New York
|
+$311M |
| 3 |
Charles Schwab
San Francisco,
California
|
+$304M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$272M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$267M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.3B |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$294M |
| 3 |
Morgan Stanley
New York
|
-$259M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$206M |
| 5 |
State Street
Boston,
Massachusetts
|
-$167M |
PFE Hedge Fund Activity: Q1 2021 in Review
2,676 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q1 2021, worth a combined $133B — down 2.5% from $137B a quarter earlier.
Buyers outnumbered sellers: 167 funds opened new PFE positions and 133 closed out — a net gain of 34 holders — while 1,222 added to existing stakes and 1,083 trimmed.
The largest buyer was Ameriprise, adding an estimated $336M. The largest seller was Capital World Investors, cutting an estimated $1.3B.
- 2,676 institutional investors held Pfizer (PFE) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $133B of Pfizer stock for Q1 2021, down 2.5% quarter-over-quarter.
- 167 funds opened new Pfizer positions in Q1 2021 and 133 closed out, a net change of +34 holders.
- The largest Pfizer buyer in Q1 2021 was Ameriprise, an estimated $336M added.
- The largest Pfizer seller in Q1 2021 was Capital World Investors, an estimated $1.3B sold.
Based on aggregated 13F filings for Q1 2021.